Viking Therapeutics Share Drop After Upsized Stock, Notes Offerings

By Chris WackShares of Viking Therapeutics shares fell after the company said it has priced concurrent public offerings of 7.9 million shares at $35 a share, and $225 million of 2.00% convertible senior notes due 2032.The stock was 12% lower, at $36.58, in premarket trade.The offering sizes of the…